Literature DB >> 28322619

Raising the Bar for Traumatic Brain Injury Biomarker Research: Methods Make a Difference.

Linda Papa1,2, Kevin K W Wang3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28322619      PMCID: PMC5510666          DOI: 10.1089/neu.2017.5030

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


× No keyword cloud information.
  15 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 2.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

3.  Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity vs a Contemporary Assay in Patients Presenting to the Emergency Department.

Authors:  Sara A Love; Yader Sandoval; Stephen W Smith; Jennifer Nicholson; Jing Cao; Ranka Ler; Karen Schulz; Fred S Apple
Journal:  Clin Chem       Date:  2016-06-20       Impact factor: 8.327

4.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Authors:  Linda Papa; Salvatore Silvestri; Gretchen M Brophy; Philip Giordano; Jay L Falk; Carolina F Braga; Ciara N Tan; Neema J Ameli; Jason A Demery; Neha K Dixit; Matthew E Mendes; Ronald L Hayes; Kevin K W Wang; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2014-09-12       Impact factor: 5.269

5.  Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.

Authors:  Lawrence M Lewis; Derek T Schloemann; Linda Papa; Robert P Fucetola; Jeffrey Bazarian; Miranda Lindburg; Robert D Welch
Journal:  Acad Emerg Med       Date:  2017-05-18       Impact factor: 3.451

6.  Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.

Authors:  Ramon Diaz-Arrastia; Kevin K W Wang; Linda Papa; Marco D Sorani; John K Yue; Ava M Puccio; Paul J McMahon; Tomoo Inoue; Esther L Yuh; Hester F Lingsma; Andrew I R Maas; Alex B Valadka; David O Okonkwo; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2013-10-09       Impact factor: 5.269

7.  Incidence rate of mild traumatic brain injury among patients who have suffered from an isolated limb fracture: Upper limb fracture patients are more at risk.

Authors:  Marianne Jodoin; Dominique M Rouleau; Camille Charlebois-Plante; Benoit Benoit; Stéphane Leduc; G-Yves Laflamme; Nadia Gosselin; Camille Larson-Dupuis; Louis De Beaumont
Journal:  Injury       Date:  2016-05-27       Impact factor: 2.586

8.  Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Are Not Specific Biomarkers for Mild CT-Negative Traumatic Brain Injury.

Authors:  Jussi P Posti; Iftakher Hossain; Riikka S K Takala; Hilkka Liedes; Virginia Newcombe; Joanne Outtrim; Ari J Katila; Janek Frantzén; Henna Ala-Seppälä; Jonathan P Coles; Anna Kyllönen; Henna-Riikka Maanpää; Jussi Tallus; Peter J Hutchinson; Mark van Gils; David K Menon; Olli Tenovuo
Journal:  J Neurotrauma       Date:  2017-01-27       Impact factor: 5.269

9.  The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.

Authors:  Jussi P Posti; Riikka S K Takala; Hilkka Runtti; Virginia F Newcombe; Joanne Outtrim; Ari J Katila; Janek Frantzén; Henna Ala-Seppälä; Jonathan P Coles; Md Iftakher Hossain; Anna Kyllönen; Henna-Riikka Maanpää; Jussi Tallus; Peter J Hutchinson; Mark van Gils; David K Menon; Olli Tenovuo
Journal:  Neurosurgery       Date:  2016-09       Impact factor: 4.654

10.  Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.

Authors:  Robert D Welch; Syed I Ayaz; Lawrence M Lewis; Johan Unden; James Y Chen; Valerie H Mika; Ben Saville; Joseph A Tyndall; Marshall Nash; Andras Buki; Pal Barzo; Dallas Hack; Frank C Tortella; Kara Schmid; Ronald L Hayes; Arastoo Vossough; Stephen T Sweriduk; Jeffrey J Bazarian
Journal:  J Neurotrauma       Date:  2015-12-18       Impact factor: 5.269

View more
  9 in total

1.  Concussion BASICS II: Baseline serum biomarkers, head impact exposure, and clinical measures.

Authors:  Breton M Asken; Russell M Bauer; Steven T DeKosky; Zachary M Houck; Charles C Moreno; Michael S Jaffee; Dewayne N Dubose; Jonathan K Boone; Arthur G Weber; James R Clugston
Journal:  Neurology       Date:  2018-11-07       Impact factor: 9.910

2.  Acute inhalation of combustion smoke triggers neuroinflammation and persistent anxiety-like behavior in the mouse.

Authors:  Murat F Gorgun; Ming Zhuo; IbDanelo Cortez; Kelly T Dineley; Ella W Englander
Journal:  Inhal Toxicol       Date:  2018-02-06       Impact factor: 2.724

3.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

4.  Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury.

Authors:  Linnéa Lagerstedt; Juan José Egea-Guerrero; Ana Rodríguez-Rodríguez; Alejandro Bustamante; Joan Montaner; Amir El Rahal; Elisabeth Andereggen; Lara Rinaldi; Asita Sarrafzadeh; Karl Schaller; Jean-Charles Sanchez
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

5.  Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study.

Authors:  Linda Papa; Mark R Zonfrillo; Robert D Welch; Lawrence M Lewis; Carolina F Braga; Ciara N Tan; Neema J Ameli; Marco A Lopez; Crystal A Haeussler; Diego Mendez Giordano; Philip A Giordano; Jose Ramirez; Manoj K Mittal
Journal:  BMJ Paediatr Open       Date:  2019-08-25

Review 6.  Advances in Traumatic Brain Injury Biomarkers.

Authors:  Kengo Nishimura; Joacir G Cordeiro; Aminul I Ahmed; Shoji Yokobori; Shyam Gajavelli
Journal:  Cureus       Date:  2022-04-04

7.  A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury.

Authors:  Sima Azizi; Daniel B Hier; Blaine Allen; Tayo Obafemi-Ajayi; Gayla R Olbricht; Matthew S Thimgan; Donald C Wunsch
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

8.  The delayed detection of an acute neurological worsening increases traumatic brain injury lethality

Authors:  Alexander Rodríguez; Eliana Cervera; Rafael Tuesca; Karen Flórez; Ricardo Romero; Pedro J Villalba
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

Review 9.  Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients.

Authors:  Steven T DeKosky; Patrick M Kochanek; Alex B Valadka; Robert S B Clark; Sherry H-Y Chou; Alicia K Au; Christopher Horvat; Ruchira M Jha; Rebekah Mannix; Stephen R Wisniewski; Max Wintermark; Susan E Rowell; Robert D Welch; Lawrence Lewis; Stacey House; Rudolph E Tanzi; Darci R Smith; Amy Y Vittor; Nancy D Denslow; Michael D Davis; Olena Y Glushakova; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2020-11-11       Impact factor: 5.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.